Document Detail


CYP1A2 polymorphisms in slow melatonin metabolisers: a possible relationship with autism spectrum disorder?
MedLine Citation:
PMID:  22823064     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Background  In some of our patients with intellectual disabilities (ID) and sleep problems, the initial good response to melatonin disappeared within a few weeks after starting treatment. In these patients melatonin levels at noon were extremely high (>50 pg/ml). We hypothesise that the disappearing effectiveness is associated with slow metabolisation of melatonin because of a single nucleotide polymorphism (SNP) of CYP1A2. Method  In this pilot study we analysed DNA extracted from saliva samples of 15 consecutive patients with disappearing effectiveness of melatonin. Saliva was collected at noon and 4 pm for measuring melatonin levels. Results  In all patients' salivary melatonin levels at noon were >50 or melatonin half time was >5 h. A SNP was found in eight of 15 patients. The allele *1C was found in two patients and in six patients the *1F allele was found. Conclusions  Of 15 patients with disappearing effectiveness of melatonin, seven were diagnosed with autism spectrum disorder, and in four of them a SNP was found. The other eight patients were known with a genetic syndrome. In six of them behaviour was considered to be autistic-type and in three of them a SNP was found. This finding may give a new direction for research into the genetic background of autism.
Authors:
W Braam; H Keijzer; H Struijker Boudier; R Didden; M Smits; L Curfs
Related Documents :
8192534 - The effect of subcutaneous recombinant human erythropoietin (r-hu epo) in capd patients...
17986564 - Hypoproteinemia in patients with diabetes undergoing continuous ambulatory peritoneal d...
8865864 - Renal function influences interleukin-8 background production by cultured human mesothe...
22364664 - Influence of smoking on interleukin-1beta level, oxidant status and antioxidant status ...
18397714 - Clinical manifestation of gadodiamide-related nephrogenic systemic fibrosis.
21475314 - Prevalence of ocular motor cranial nerve palsy and associations following stroke.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-7-23
Journal Detail:
Title:  Journal of intellectual disability research : JIDR     Volume:  -     ISSN:  1365-2788     ISO Abbreviation:  -     Publication Date:  2012 Jul 
Date Detail:
Created Date:  2012-7-24     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9206090     Medline TA:  J Intellect Disabil Res     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© 2012 The Authors. Journal of Intellectual Disability Research © 2012 Blackwell Publishing Ltd.
Affiliation:
Department Advisium, 's Heeren Loo Zuid-Veluwe, Wekerom, The Netherlands Department of Clinical Chemistry, Rijnstate Hospital, Arnhem, The Netherlands Department of Pharmacology and Toxicology, Maastricht University, Maastricht, The Netherlands Special Education, Behavioural Science Institute, Radboud University Nijmegen, Nijmegen, The Netherlands Department of Neurology, Gelderse Vallei Hospital, Ede, The Netherlands Department of Clinical Genetics, University Maastricht/Academic Hospital, Maastricht, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The Effect of Delivery Method on Breastfeeding Initiation from the The Ontario Mother and Infant Stu...
Next Document:  Synergistic Effects from Graphene and Carbon Nanotubes Enable Flexible and Robust Electrodes for Hig...